Pathogenesis of varicelloviruses in primates

Journal of Pathology

Volumn 235, Issue 2, 2015, Pages 298-311

  Ouwendijk, Werner J D ^a   Verjans, Georges M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dissemination; Humans; Immunity; Latency; Non human primates; Primary infection; Reactivation; Simian varicella virus; Varicella zoster virus

Indexed keywords

ARTICLE; CHICKENPOX; CLINICAL FEATURE; ENDEMIC DISEASE; HERPES ZOSTER; HOST PATHOGEN INTERACTION; IMMUNOCOMPROMISED PATIENT; LATENT VIRUS INFECTION; PRIMARY INFECTION; PRIMATE; VARICELLA ZOSTER VIRUS; VARICELLOVIRUS; VIREMIA; VIRUS PATHOGENESIS; VIRUS REACTIVATION; ANIMAL; BIOPSY; DISEASE MODEL; GENETICS; GENOTYPE; HERPES VIRUS INFECTION; HUMAN; IMMUNOLOGY; MOLECULAR PATHOLOGY; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; VIROLOGY; VIRULENCE; VIRUS ACTIVATION; VIRUS LATENCY;

ANIMALS; BIOPSY; DISEASE MODELS, ANIMAL; GENOTYPE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; PRIMATES; VARICELLOVIRUS; VIROLOGY; VIRULENCE; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84917706627     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4451     Document Type: Article

References (175)

1. Von Bokay J. Uber den atiologischen Zusammenhang der Varizellen mit gewissen Fallen von Herpes Zoster. Wien Klin Wochensch 1909; 22: 1323-1326.
2. Garland J. Varicella following exposure to herpes zoster. N Engl J Med 1943: 228: 336-337.
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
4. Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med 1958; 108: 843-868.
5. Arvin AM, Gilden, D. Varicella-zoster virus. In Fields Virology, 6th edn, Knipe DM, Howley PM (eds). Lippincott Williams and Wilkins: Philadelphia, PA, 2013; 2015-2057.
6. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992; 166(suppl 1): S1-6.
7. Clarkson MJ, Thorpe E and McCarthy K. A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus. Arch Gesamte Virusforsch 1967; 22: 219-234.
8. Allen WP, Felsenfeld AD, Wolf RH, et al. Recent studies on the isolation and characterization of δ-herpesvirus. Lab Anim Sci 1974; 24: 222-228.
9. Blakely GA, Lourie B, Morton WG, et al. A varicella-like disease in macaque monkeys. J Infect Dis 1973; 127: 617-625.
10. McCarthy K, Thorpe E, Laursen AC, et al. Exanthematous disease in patas monkeys caused by a herpes virus. Lancet 1968; 292: 856-857.
11. Schmidt NJ, Arvin AM, Martin DP, et al. Serological investigation of an outbreak of simian varicella in Erythrocebus patas monkeys. J Clin Microbiol 1983; 18: 901-904.
12. Wolf RH, Smetana HF. Allen WP, et al. Pathology and clinical history of δ-herpesvirus infection in patas monkeys. Lab Anim Sci 1974; 24: 218-221.
13. Dueland AN, Martin JR, Devlin ME, et al. Acute simian varicella infection. Clinical, laboratory, pathologic, and virological features. Lab Invest 1992; 66; 762-773.
14. Gray WL, Gusick NJ, Fletcher TM, et al. Simian varicella virus antibody response in experimental infection of African green monkeys. J Med Primatol 1995; 24: 246-251.
15. Gray WL, Williams RJ, Chang R, et al. Experimental simian varicella virus infection of St. Kitts vervet monkeys. J Med Primatol 1998; 27: 177-183.
16. Messaoudi I, Barron A, Wellish M, et al. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog 2009; 5: e1000657.
17. Ouwendijk WJ, Mahalingam R, Traina-Dorge V, et al. Simian varicella virus infection of Chinese rhesus macaques produces gan-glionic infection in the absence of rash. J Neurovirol 2012; 18: 91-99.
18. Wenner HA, Abel D, Barrick S, et al. Clinical and pathogenetic studies of Medical Lake macaque virus infections in cynomolgus monkeys (simian varicella). J Infec Dis 1997; 135: 611-622.
19. McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Viru s Res 2006; 117: 90-104.
20. Grose C. Pangaea and the out-of-Africa model for varicella-zoster virus evolution and phylogeography. J Virol 2012; 86: 9558-9565.
21. Stevens NJ, Seiffert ER, O'Connor PM, et al. Palaeontological evidence for an Oligocene divergence between Old World monkeys and apes. Nature 2013; 497: 611-614.
22. Fletcher TM, Gray WL. Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus. J Gen Virol 1992; 73: 1209-1215.
23. CDC/Dr Erskine Palmer; BG Partin. Available from: http://phil. cdc.gov/phil/details.asp?pid=1878
24. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67: 1759-1816.
25. Gray WL, Starnes B, White MW, et al. The DNA sequence of the simian varicella virus genome. Virology 2001; 284: 123-130.
26. Mahalingam R, Gray WL. The simian varicella virus genome contains an invertible 665 base pair terminal element that is absent in the varicella zoster virus genome. Virology 2007; 366: 387-393.
27. Che X, Oliver SL, Reichelt M, et al. ORF11 protein interacts with the ORF9 essential tegument protein in varicella-zoster virus infection. J Virol 2013; 87: 5106-5117.
28. Kinchington PR, Hougland JK, Arvin AM, et al. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol 1992; 66: 359-366.
29. Kinchington PR, Bookey D, Turse SE. The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purifed virus particles. J Virol 1996; 69: 4274-4282.
30. Leisenfelder SA, Kinchington PR, Moffat JF. Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions. J Virol 2008; 82: 12116-12125.
31. Stevenson D, Colman KL, Davison AJ. Characterization of the putative protein kinases specifed by varicella-zoster virus genes 47 and 66. J Gen Virol 1994; 75: 317-326.
32. Ambagala AP, Cohen JI. Varicella-zoster virus IE63, a major viral latency protein, is required to inhibit the α-interferon-induced antiviral response. J Virol 2007; 81: 7844-7851.
33. Eisfeld AJ, Yee MB, Erazo A, et al. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and-independent mechanisms. J Virol 2007; 81: 9034-9049.
34. Sen N, Sommer M, Che X, et al. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J Virol 2010; 84: 9240-9253.
35. Vandevenne P, Lebrun M, El Mjiyad N, et al. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS One 2011; 6: e16870.
36. Storlie J, Maresova L, Jackson W, et al. Comparative analyses of the nine glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus. J Infect Dis 2008; 197(suppl 2): S49-53.
37. Zhu Z, Gershon MD, Ambron R, et al. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA 1995; 92: 3546-3550.
38. Chen JJ, Zhu Z, Gershon AA, et al. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 2004; 119: 915-926.
39. Suenaga T, Satoh T, Somboonthum P, et al. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sci USA 2010; 107: 866-871.
40. Li Q, Ali MA, Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 2006; 127: 305-316.
41. Carpenter JE, Jackson W, de Souza GA, et al. Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmatic reticulum. J Virol 2010; 84: 847-855.
42. Cheatham WJ, Dolan TF, Dower JC, et al. Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am J Pathol 1956; 32: 1015-1035.
43. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In Fields Virology, 6th edn, Knipe DM, Howley PM (eds). Lippincott Williams and Wilkins: Philadelphia, PA, 2013: 1823-1897.
44. Lenac Rovis T, Bailer SM, Pothineni VR, et al. Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection. J Virol 2013; 87: 6943-6954.
45. Reichelt M, Brady J, Arvin AM. The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol 2009; 83: 3904-3918.
46. Carpenter JE, Hutchinson JA, Jackson W, et al. Egress of light particles among flopodia on the surface of varicella-zoster virus-infected cells. J Virol 2008; 82: 2821-2835.
47. Gershon AA, Sherman DL, Zhu Z, et al. Intracellular transport of newly synthesized varicella-zoster virus: fnal envelopment in the trans-Golgi network. J Virol 1994; 68: 6372-6390.
48. Hambleton S, Gershon MD, Gershon AA. The role of the trans-Golgi network in varicella zoster virus biology. Cell Mol Life Sci 2004; 61: 3047-3056.
49. Harson R, Grose C. Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol 1995; 69: 4994-5010.
50. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 1981; 68: 735-737.
51. LeClair JM, Zaia JA, Levin MJ, et al. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980; 302: 450-453.
52. Heininger U, Seward JF. Varicella. Lancet 2006; 368: 1365-1376.
53. Johnson R, Milbourn PE. Central nervous system manifestations of chickenpox. Can Med Assoc J 1970; 102: 831-834.
54. Koskiniemi M, Piiparinen H, Rantalaiho T, et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002; 25: 293-301.
55. Barak M, Weinberger R. Outcome of IgM-and IgG-seropositive cases of varicella zoster in pregnancy. J Reprod Med 2004; 49: 38-40.
56. Christiansen D, Barret ED. Comparison of varicella history with presence of varicella antibody in refugees. Vaccine 2004; 22: 4233-4237.
57. Kolappaswamy K, Mahalingam R, Traina-Dorge V, et al. Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J Virol 2007; 81: 411-415.
58. Ward TM, Traina-Dorge V, Davis KA, et al. Recombinant simian varicella expressing respiratory syncytial virus antigens are immunogenic. J Gen Virol 2008; 89: 741-750.
59. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(suppl 1): S1-26.
60. Gilden D, Nagel MA, Cohrs RJ, et al. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neu-rosci Rep 2013; 13: 374.
61. Liesegang TJ. Varicella-zoster virus eye disease. Cornea 1999; 18: 511-531.
62. Ritterband DC, Friedberg DN. Virus infections of the eye. Rev Med Vi ro l 1998; 8: 187-201.
63. Nagel MA, Gilden D. Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep 2014; 16: 407.
64. Breuer J, Pacou M, Gauthier A, et al. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 2014; 82: 206-212.
65. Sreenivasan N, Basit S, Wohlfahrt J, et al. The short-and long-term risk of stroke after herpes zoster-a nationwide population-based cohort study. PLoS One 2013; 8: e69156.
66. Gilden D. Association of varicella zoster virus with giant cell arteri-tis. Monoclon Antib Immunodiagn Immunother 2014; 33: 168-172.
67. Nagel MA, Khmeleva N, Boyer PJ, et al. Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci 2013; 335: 228-230.
68. Ness T, Bley TA, Schmidt WA, et al. The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int 2013; 110: 376-385; quiz, 386.
69. Chen JJ, Gershon AA, Li Z, et al. Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol 2011; 17: 578-589.
70. Mahalingam R, Traina-Dorge V, Wellish M, et al. Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol 2010; 16: 342-354.
71. Mahalingam R, Traina-Dorge V, Wellish M, et al. Simian varicella virus reactivation in cynomolgus monkeys. Virolo gy 2007; 368: 50-59.
72. White TM, Mahalingam R, Traina-Dorge V, et al. Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J Neurovirol 2002; 8: 191-203.
73. + blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology 2002; 10: 192-198.
74. Mahalingam R, Traina-Dorge V, Wellish M, et al. Naturally acquired simian varicella virus infection in African green monkeys. J Virol 2002; 76: 8548-8550.
75. Metcalf JF, Christianson MD, Brady AG. Ocular inoculation of monkeys with simian varicella virus: clinical and histopathologic observations. Invest Ophthalmol Vis Sci 1995; 36: 41-51.
76. Steain M, Slobedman B, Abendroth A. The host immune response to varicella zoster virus. Future Virol 2012; 7: 1205-1220.
77. Ouwendijk WJ, Laing KJ, Verjans GM, et al. T-cell immunity to human α-herpesviruses. Curr Opin Virol 2013; 3: 452-460.
78. Zerboni L, Sen N, Oliver SL, et al. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 2014; 12: 197-210.
79. Tomlinson TH. Giant cell formation in the tonsils in the prodromal stage of chickenpox: report of a case. Am J Pathol 1939; 15: 523-526.
80. Kirby AC, Coles MC, Kaye PM. Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol 2009; 183: 1983-1989.
81. Thornton EE, Looney MR, Bose O, et al. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J Exp Med 2012; 209: 1183-1199.
82. Abendroth A, Morrow G, Cunningham AL, et al. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J Virol 2001; 75: 6183-6192.
83. Arbeit RD, Zaia JA, Valerio MA, et al. Infection of human peripheral blood mononuclear cells by varicella-zoster virus. Intervirology 1982; 18: 56-65.
84. Ouwendijk WJ, Mahalingam R, de Swart RL, et al. T-cell tropism of simian varicella virus during primary infection. PLoS Pathog 2013; 9: e1003368.
85. Dueland AN, Martin JR, Devlin ME, et al. Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest 1992; 66: 762-773.
86. Asano Y, Itakura N, Hiroishi Y, et al. Viremia is present in incubation period in 7 nonimmunocompromised children with varicella. J Pediatr 1985; 106: 69-71.
87. Asano Y, Itakura N, Hiroishi Y, et al. Viral replication and immuno-logic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 1985; 152: 863-868.
88. Koropchak CM, Graham G, Palmer J, et al. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis 1991; 163: 1016-1022.
89. Ozaki T, Ichikawa T, Matsui Y, et al. Viremic phase in nonim-munocompromised children with varicella. J Pediatr 1984; 104: 85-87.
90. Mainka C, Fuss B, Geiger H, et al. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 1998; 56: 91-98.
91. + T lymphocytes that express activation, memory, and skin homing markers. J Virol 2002; 76: 11425-11433.
92. Soong W, Schultz JC, Patera AC, et al. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 2000; 74: 1864-1870.
93. Sen N, Mukherjee G, Sen A, et al.Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Rep 2014; 24: 633-645.
94. Konig A, Homme C, Hauroder B, et al. The varicella-zoster virus induces apoptosis in vitro in subpopulations of primary human peripheral blood mononuclear cells. Microbes Infect 2003; 5: 879-889.
95. Arvin AM, Koropchak CM, Williams BR, et al. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986; 154: 422-429.
96. Mahalingam R, Wellish M, White T, et al. Infectious simian varicella virus expressing the green fuorescent protein. J Neurovirol 1998; 4: 438-444.
97. Jing L, Schiffer JT, Chong TM, et al. CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence. J Virol 2013; 87: 2617-2627.
98. + T cells responding to antigen without requiring knowledge of epitope specifcities. Blood 2007; 110: 201-210.
99. Tyzzer EE. The histology of the skin Lesions in varicella. J Med Res 1906; 14: 361-392.7.
100. Malavige GN, Jones L, Kamaladasa SD, et al. Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka. PLoS One 2008; 3: e3789.
101. Ku CC, Zerboni L, Ito H, et al. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α. J Exp Med 2004; 200: 917-925.
102. Jones M, Dry IR, Frampton D, et al. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. PLoS Pathog 2014; 10: e1003896.
103. Reichelt M, Wang L, Sommer M, et al. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog 2011; 7: e1001266.
104. Sen N, Che X, Rajamani J, et al. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc Natl Acad Sci USA 2012; 109: 600-605.
105. Braverman IM. The cutaneous microcirculation. J Investig Derma-tol Symp Proc 2000; 5: 3-9.
106. Hardy I, Gershon AA, Steinberg SP, et al. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991; 325: 1545-1550.
107. Grigoryan S, Kinchington PR, Yang IH, et al. Retrograde axonal transport of VZV: kinetic studies in hESC-derived neurons. J Neu-rovirol 2012; 18: 462-470.
108. Markus A, Grigoryan S, Sloutskin A, et al. Varicella-zoster virus (VZV) infection of neurons derived from human embryonic stem cells: direct demonstration of axonal infection, transport of VZV, and productive neuronal infection. J Virol 2011; 85: 6220-6233.
109. Myers MI, Peltier AC, Li J. Evaluating dermal myelinated nerve fbers in skin biopsy. Muscle Nerve 2013; 47: 1-11.
110. Gershon AA, Chen J, Davis L, et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc 2012; 123: 17-33; discussion, 33-15.
111. Gan L, Wang M, Chen JJ, et al. Infected peripheral blood mononu-clear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system. J Neurovirol 2014; (epub ahead of print).
112. Zerboni L, Ku CC, Jones CD, et al. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA 2005; 102: 6490-6495.
113. Mahalingam R, Wellish M, Soike K, et al. Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology 2001; 279: 339-342.
114. Furuta Y, Takasu T, Suzuki S, et al. Detection of latent varicella-zoster virus infection in human vestibular and spiral ganglia. J Med Virol 1997; 51: 214-216.
115. Gilden DH, Gesser R, Smith J, et al. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 2001; 23: 145-147.
116. Mahalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990; 323: 627-631.
117. Nagel MA, Rempel A, Huntington J, et al. Frequency and abundance of α-herpesvirus DNA in human thoracic sympathetic ganglia. J Virol 2014; 88: 8189-8192.
118. Christensen J, Steain M, Slobedman B, et al. Differentiated neurob-lastoma cells provide a highly effcient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol 2011; 85: 8436-8442.
119. Dukhovny A, Sloutskin A, Markus A, et al. Varicella-zoster virus infects human embryonic stem cell-derived neurons and neuro-spheres but not pluripotent embryonic stem cells or early progenitors. J Virol 2012; 86: 3211-3218.
120. Goodwin TJ, McCarthy M, Osterrieder N, et al. Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection. PLoS Pathog 2013; 9: e1003512.
121. Lee KS, Zhou W, Scott-McKean JJ, et al. Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One 2012; 7: e53010.
122. Yu X, Seitz S, Pointon T, et al. Varicella zoster virus infection of highly pure terminally differentiated human neurons. J Neurovirol 2013; 19: 75-81.
123. Clarke P, Beer T, Cohrs R, et al. Confguration of latent varicella-zoster virus DNA. J Virol 1995; 69: 8151-8154.
124. Kennedy PG, Grinfeld E, Gow JW. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci USA 1998; 95: 4658-4662.
125. Levin MJ, Cai GY, Manchak MD, et al. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J Virol 2003; 77: 6979-6987.
126. Wang K, Lau TY, Morales M, et al. Laser-capture microdissection: refning estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J Virol 2005; 79: 14079-14087.
127. Cohen JI, Straus, SE, Arvin, AM. Varicella-zoster virus replication, pathogenesis, and management. In Fields Virology, 5th edn, Knipe DM, Howley PM (eds). Lippincott Williams and Wilkins: Philadelphia, PA, 2007; 2773-2818.
128. Ouwendijk WJ, Flowerdew SE, et al. Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens. J Neurovirol 2012; 18: 172-180.
129. Zerboni L, Sobel RA, Lai M, et al. Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons. J Virol 2012; 86: 578-583.
130. Nagel MA, Choe A, Traktinskiy I, et al. Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol 2011; 85: 2276-2287.
131. Cohrs RJ, Srock K, Barbour MB, et al. Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol 1994; 68: 7900-7908.
132. Cohrs RJ, Barbour M, Gilden DH. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol 1996; 70: 2789-2796.
133. Cohrs RJ, Gilden DH. Varicella zoster virus transcription in latently-infected human ganglia. Anticancer Res 2003; 23: 2063-2069.
134. Cohrs RJ, Gilden DH. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J Virol 2007; 81: 2950-2956.
135. Croen KD, Ostrove JM, Dragovic LJ, et al. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 1988; 85: 9773-9777.
136. Kennedy PG, Grinfeld E, Bell JE. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol 2000; 74: 11893-11898.
137. Ouwendijk WJ, Choe A, Nagel MA, et al. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol 2012; 86: 10203-10206.
138. Gary L, Gilden DH, Cohrs RJ. Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia. J Virol 2006; 80: 4921-4926.
139. Yordy B, Iijima N, Huttner A, et al. A neuron-specifc role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 2012; 12: 334-345.
140. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 2005; 48: 457-476.
141. van Velzen M, Laman JD, Kleinjan A, et al. Neuron-interacting satellite glial cells in human trigeminal ganglia have an APC phe-notype. J Immunol 2009; 183: 2456-2461.
142. Kennedy PG, Grinfeld E, Traina-Dorge V, et al. Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes 2004; 28: 273-276.
143. Mahalingam R, Smith D, Wellish M, et al. Simian varicella virus DNA in dorsal root ganglia. Proc Natl Acad Sci USA 1991; 88: 2750-2752.
144. Mahalingam R, Clarke P, Wellish M, et al. Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology 1992; 188: 193-197.
145. Ou Y, Davis KA, Traina-Dorge V, et al. Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol 2007; 81: 8149-8156.
146. Meyer C, Kerns A, Barron A, et al. Simian varicella virus gene expression during acute and latent infection of rhesus macaques. J Neurovirol 2011; 17: 600-612.
147. Meyer C, Dewane J, Kerns A, et al. Age and immune status of rhesus macaques impact simian varicella virus gene expression in sensory ganglia. J Virol 2013; 87: 8294-8306.
148. Meyer C, Kerns A, Haberthur K, et al. Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61. J Virol 2013; 87: 2151-2163.
149. Stevens JG, Wagner EK, Devi-Rao GB, et al. RNA complementary to a herpesvirus-α gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056-1059.
150. Umbach JL, Kramer MF, Jurak I, et al. MicroRNAs expressed by herpes simplex virus1 during latent infection regulate viral mRNAs. Nature 2008; 454: 780-783.
151. Depledge DP, Kundu S, Jensen NJ, et al. Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol Biol Evol 2014; 31: 397-409.
152. Gebhardt T, Wakim LM, Eidsmo L, et al. Memory T cells in non-lymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009; 10: 524-530.
153. + T cells reduces viral reactivation from latency in sensory ganglia. J Immunol 2013; 191: 2258-2265.
154. Theil D, Derfuss T, Paripovic I, et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003; 163: 2179-2184.
155. van Velzen M, Jing L, Osterhaus AD, et al. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog 2013; 9: e1003547.
156. Verjans GM, Hintzen RQ, van Dun JM, et al. Selective retention of herpes simplex virus-specifc T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 2007; 104: 3496-3501.
157. Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142: 291-293.
158. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specifc cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003; 188: 1336-1344.
159. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980; 30: 582-587.
160. Devlin ME, Gilden DH, Mahalingam R, et al. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis 1992; 165: 619-622.
161. Nagel MA, Choe A, Cohrs RJ, et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 2011; 204: 820-824.
162. van Velzen M, Ouwendijk WJ, Selke S, et al. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol 2013; 85: 1669-1677.
163. Esiri MM, Tomlinson AH. Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofuorescence and electron microscopy. J Neurol Sci 1972; 15: 35-48.
164. Nagashima K, Nakazawa M, Endo H. Pathology of the human spinal ganglia in varicella-zoster virus infection. Acta Neuropathol 1975; 33: 105-117.
165. Shibuta H, Ishikawa T, Hondo R, et al. Varicella virus isolation from spinal ganglion. Arch Gesamte Virusforsch 1974; 45: 382-385.
166. Head H, Campbell AW. The pathology of herpes zoster and its bearing on sensory localisation. Brain 1900; 23: 353-523.
167. Gowrishankar K, Steain M, Cunningham AL, et al. Characterization of the host immune response in human ganglia after herpes zoster. J Virol 2010; 84: 8861-8870.
168. Steain M, Sutherland JP, Rodriguez M, et al. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol 2014; 88: 2704-2716.
169. Steain M, Gowrishankar K, Rodriguez M, et al. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection. J Virol 2011; 85: 626-631.
170. Ouwendijk WJ, Abendroth A, Traina-Dorge V, et al. T-cell infltra-tion correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus. J Virol 2013; 87: 2979-2982.
171. Mahalingam R, Traina-Dorge V, Wellish M, et al. Simian varicella virus reactivation in cynomolgus monkeys. Virolo gy 2007; 368: 50-59.
172. Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of two doses of varicella vaccine in children. J Infect Dis 2011; 203: 312-315.
173. Takahashi M, Otsuka T, Okuno Y, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288-1290.
174. Gershon AA, Gershon MD. Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol 2010; 342: 359-372.
175. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.